Annual Operating Profit
-$4.53 M
-$969.20 K-27.24%
31 December 2023
Summary:
Protagenic Therapeutics annual operaing income is currently -$4.53 million, with the most recent change of -$969.20 thousand (-27.24%) on 31 December 2023. During the last 3 years, it has fallen by -$1.98 million (-77.42%). PTIX annual operating profit is now -346.70% below its all-time high of $1.83 million, reached on 31 July 2000.PTIX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$652.10 K
+$1.02 M+60.89%
30 September 2024
Summary:
Protagenic Therapeutics quarterly operating income is currently -$652.10 thousand, with the most recent change of +$1.02 million (+60.89%) on 30 September 2024. Over the past year, it has increased by +$779.60 thousand (+54.45%). PTIX quarterly operating profit is now -119.76% below its all-time high of $3.30 million, reached on 31 October 1996.PTIX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$5.27 M
+$779.60 K+12.89%
30 September 2024
Summary:
Protagenic Therapeutics TTM operating income is currently -$5.27 million, with the most recent change of +$779.60 thousand (+12.89%) on 30 September 2024. Over the past year, it has dropped by -$1.30 million (-32.73%). PTIX TTM operating profit is now -259.70% below its all-time high of $3.30 million, reached on 31 October 1996.PTIX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.2% | +54.5% | -32.7% |
| 3 y3 years | -77.4% | +14.7% | -38.1% |
| 5 y5 years | -95.6% | -243.9% | -181.3% |
PTIX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -77.4% | at low | -2.4% | +62.5% | -78.3% | +12.9% |
| 5 y | 5 years | -117.0% | at low | -243.9% | +62.5% | -181.3% | +12.9% |
| alltime | all time | -346.7% | +74.0% | -119.8% | +89.3% | -259.7% | +71.7% |
Protagenic Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$652.10 K(-60.9%) | -$5.27 M(-12.9%) |
| June 2024 | - | -$1.67 M(-4.1%) | -$6.05 M(+9.5%) |
| Mar 2024 | - | -$1.74 M(+43.4%) | -$5.53 M(+22.1%) |
| Dec 2023 | -$4.53 M(+27.2%) | -$1.21 M(-15.3%) | -$4.53 M(+14.0%) |
| Sept 2023 | - | -$1.43 M(+25.2%) | -$3.97 M(+14.7%) |
| June 2023 | - | -$1.14 M(+54.7%) | -$3.46 M(+17.2%) |
| Mar 2023 | - | -$739.30 K(+12.7%) | -$2.96 M(-16.9%) |
| Dec 2022 | -$3.56 M(-14.1%) | -$655.80 K(-29.0%) | -$3.56 M(-5.5%) |
| Sept 2022 | - | -$924.10 K(+45.1%) | -$3.76 M(+4.4%) |
| June 2022 | - | -$636.70 K(-52.5%) | -$3.60 M(-15.7%) |
| Mar 2022 | - | -$1.34 M(+55.7%) | -$4.28 M(+3.3%) |
| Dec 2021 | -$4.14 M(+62.3%) | -$861.20 K(+12.7%) | -$4.14 M(+8.5%) |
| Sept 2021 | - | -$764.20 K(-41.6%) | -$3.82 M(-7.9%) |
| June 2021 | - | -$1.31 M(+8.5%) | -$4.14 M(+24.7%) |
| Mar 2021 | - | -$1.21 M(+124.7%) | -$3.32 M(+26.0%) |
| Dec 2020 | -$2.55 M(+22.3%) | -$536.90 K(-50.8%) | -$2.64 M(-7.1%) |
| Sept 2020 | - | -$1.09 M(+123.4%) | -$2.84 M(+46.6%) |
| June 2020 | - | -$488.90 K(-6.1%) | -$1.94 M(-0.8%) |
| Mar 2020 | - | -$520.70 K(-29.4%) | -$1.95 M(-6.4%) |
| Dec 2019 | -$2.09 M(-9.9%) | -$737.20 K(+288.8%) | -$2.09 M(+11.4%) |
| Sept 2019 | - | -$189.60 K(-62.5%) | -$1.87 M(-14.1%) |
| June 2019 | - | -$505.30 K(-22.7%) | -$2.18 M(-7.6%) |
| Mar 2019 | - | -$654.00 K(+24.8%) | -$2.36 M(+2.0%) |
| Dec 2018 | -$2.31 M(-2.2%) | -$524.20 K(+5.2%) | -$2.31 M(-7.4%) |
| Sept 2018 | - | -$498.10 K(-27.3%) | -$2.50 M(-1.1%) |
| June 2018 | - | -$685.10 K(+12.9%) | -$2.53 M(+9.2%) |
| Mar 2018 | - | -$606.70 K(-14.4%) | -$2.31 M(-2.2%) |
| Dec 2017 | -$2.37 M(+29.3%) | -$708.80 K(+34.5%) | -$2.37 M(+6.9%) |
| Sept 2017 | - | -$527.00 K(+11.7%) | -$2.21 M(+3.4%) |
| June 2017 | - | -$471.60 K(-28.3%) | -$2.14 M(-1.2%) |
| Mar 2017 | - | -$657.90 K(+18.3%) | -$2.17 M(+18.4%) |
| Dec 2016 | -$1.83 M(+272.6%) | -$556.30 K(+22.3%) | -$1.83 M(+28.5%) |
| Sept 2016 | - | -$454.80 K(-8.4%) | -$1.42 M(+29.5%) |
| June 2016 | - | -$496.70 K(+54.4%) | -$1.10 M(+53.4%) |
| Mar 2016 | - | -$321.60 K(+113.0%) | -$716.60 K(+38.9%) |
| Dec 2015 | - | -$151.00 K(+16.2%) | -$516.00 K(+2.8%) |
| Sept 2015 | - | -$130.00 K(+14.0%) | -$502.00 K(+2.4%) |
| June 2015 | -$491.00 K(-49.6%) | -$114.00 K(-5.8%) | -$490.00 K(-3.2%) |
| Mar 2015 | - | -$121.00 K(-11.7%) | -$506.00 K(-35.4%) |
| Dec 2014 | - | -$137.00 K(+16.1%) | -$783.00 K(-11.8%) |
| Sept 2014 | - | -$118.00 K(-9.2%) | -$888.00 K(-9.0%) |
| June 2014 | -$975.00 K(+44.9%) | -$130.00 K(-67.3%) | -$976.00 K(+15.4%) |
| Mar 2014 | - | -$398.00 K(+64.5%) | -$846.00 K(+88.8%) |
| Dec 2013 | - | -$242.00 K(+17.5%) | -$448.00 K(+117.5%) |
| Sept 2013 | - | -$206.00 K(-94.3%) | -$206.00 K(-98.9%) |
| June 2013 | -$673.00 K(-96.1%) | - | - |
| Sept 2011 | - | -$3.60 M(-28.4%) | -$18.55 M(-0.4%) |
| June 2011 | - | -$5.02 M(+30.3%) | -$18.62 M(+3.0%) |
| Mar 2011 | - | -$3.85 M(-36.5%) | -$18.08 M(+3.6%) |
| Dec 2010 | -$17.45 M | -$6.07 M(+65.5%) | -$17.45 M(+31.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$3.67 M(-18.3%) | -$13.25 M(-9.5%) |
| June 2010 | - | -$4.49 M(+39.4%) | -$14.64 M(+12.6%) |
| Mar 2010 | - | -$3.22 M(+72.0%) | -$13.01 M(+12.4%) |
| Dec 2009 | -$11.57 M(+401.6%) | -$1.87 M(-63.0%) | -$11.57 M(-10.2%) |
| Sept 2009 | - | -$5.07 M(+77.8%) | -$12.89 M(+59.8%) |
| June 2009 | - | -$2.85 M(+59.4%) | -$8.07 M(+132.5%) |
| Mar 2009 | - | -$1.79 M(-43.9%) | -$3.47 M(+67.8%) |
| Dec 2008 | -$2.31 M(-58.0%) | -$3.19 M(+1200.0%) | -$2.07 M(+6359.4%) |
| Sept 2008 | - | -$245.00 K(-114.0%) | -$32.00 K(-98.3%) |
| June 2008 | - | $1.75 M(-554.0%) | -$1.91 M(-66.0%) |
| Mar 2008 | - | -$385.00 K(-66.5%) | -$5.61 M(+2.1%) |
| Dec 2007 | -$5.50 M(-473.1%) | -$1.15 M(-45.8%) | -$5.50 M(+26.4%) |
| Sept 2007 | - | -$2.12 M(+8.3%) | -$4.35 M(+93.9%) |
| June 2007 | - | -$1.96 M(+622.5%) | -$2.24 M(-14.6%) |
| Mar 2007 | - | -$271.00 K(+1781.9%) | -$2.63 M(+17.5%) |
| Dec 2006 | $1.47 M(-2176.1%) | - | - |
| Oct 2006 | - | -$14.40 K(-99.4%) | -$2.23 M(-1.6%) |
| July 2006 | - | -$2.34 M(-1900.0%) | -$2.27 M(-3347.6%) |
| July 2006 | -$71.00 K(-24.9%) | - | - |
| Apr 2006 | - | $130.00 K(-1440.2%) | $69.90 K(-216.3%) |
| Jan 2006 | - | -$9700.00(-80.8%) | -$60.10 K(+19.2%) |
| Oct 2005 | - | -$50.40 K(-73.6%) | -$50.40 K(-96.7%) |
| July 2005 | -$94.50 K(<-9900.0%) | - | - |
| July 2004 | $0.00(-100.0%) | - | - |
| Apr 2003 | - | -$191.00 K(-51.9%) | -$1.51 M(+7.2%) |
| Jan 2003 | - | -$397.00 K(+2.6%) | -$1.41 M(+17.4%) |
| Oct 2002 | - | -$387.00 K(-27.3%) | -$1.20 M(+126.9%) |
| July 2002 | -$528.00 K(-170.7%) | -$532.00 K(+491.1%) | -$528.00 K(+95.6%) |
| Apr 2002 | - | -$90.00 K(-52.4%) | -$270.00 K(+500.0%) |
| Jan 2002 | - | -$189.00 K(-166.8%) | -$45.00 K(-109.7%) |
| Oct 2001 | - | $283.00 K(-203.3%) | $463.00 K(-38.0%) |
| July 2001 | $747.00 K(-59.3%) | -$274.00 K(-303.0%) | $747.00 K(-50.4%) |
| Apr 2001 | - | $135.00 K(-57.7%) | $1.51 M(-12.7%) |
| Jan 2001 | - | $319.00 K(-43.7%) | $1.73 M(-4.5%) |
| Oct 2000 | - | $567.00 K(+16.7%) | $1.81 M(-3.7%) |
| July 2000 | $1.83 M(-767.3%) | $486.00 K(+37.3%) | $1.88 M(+166.9%) |
| Apr 2000 | - | $354.00 K(-11.5%) | $703.00 K(+199.1%) |
| Jan 2000 | - | $400.00 K(-37.1%) | $235.00 K(+571.4%) |
| Oct 1999 | - | $636.00 K(-192.6%) | $35.00 K(-117.4%) |
| July 1999 | -$275.00 K(-131.8%) | -$687.00 K(+502.6%) | -$201.00 K(-130.8%) |
| Apr 1999 | - | -$114.00 K(-157.0%) | $652.00 K(-44.1%) |
| Jan 1999 | - | $200.00 K(-50.0%) | $1.17 M(+20.7%) |
| Oct 1998 | - | $400.00 K(+141.0%) | $966.00 K(+11.5%) |
| July 1998 | $866.00 K(-244.3%) | $166.00 K(-58.5%) | $866.00 K(+44.3%) |
| Apr 1998 | - | $400.00 K(>+9900.0%) | $600.00 K(+100.0%) |
| Jan 1998 | - | $0.00(-100.0%) | $300.00 K(-250.0%) |
| Oct 1997 | - | $300.00 K(-400.0%) | -$200.00 K(-107.1%) |
| July 1997 | -$600.00 K | -$100.00 K(-200.0%) | $2.80 M(-3.4%) |
| Apr 1997 | - | $100.00 K(-120.0%) | $2.90 M(+3.6%) |
| Jan 1997 | - | -$500.00 K(-115.2%) | $2.80 M(-15.2%) |
| Oct 1996 | - | $3.30 M | $3.30 M |
FAQ
- What is Protagenic Therapeutics annual operaing income?
- What is the all time high annual operating profit for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual operating profit year-on-year change?
- What is Protagenic Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly operating profit year-on-year change?
- What is Protagenic Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Protagenic Therapeutics?
- What is Protagenic Therapeutics TTM operating profit year-on-year change?
What is Protagenic Therapeutics annual operaing income?
The current annual operating profit of PTIX is -$4.53 M
What is the all time high annual operating profit for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual operaing income is $1.83 M
What is Protagenic Therapeutics annual operating profit year-on-year change?
Over the past year, PTIX annual operaing income has changed by -$969.20 K (-27.24%)
What is Protagenic Therapeutics quarterly operating income?
The current quarterly operating profit of PTIX is -$652.10 K
What is the all time high quarterly operating profit for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly operating income is $3.30 M
What is Protagenic Therapeutics quarterly operating profit year-on-year change?
Over the past year, PTIX quarterly operating income has changed by +$779.60 K (+54.45%)
What is Protagenic Therapeutics TTM operating income?
The current TTM operating profit of PTIX is -$5.27 M
What is the all time high TTM operating profit for Protagenic Therapeutics?
Protagenic Therapeutics all-time high TTM operating income is $3.30 M
What is Protagenic Therapeutics TTM operating profit year-on-year change?
Over the past year, PTIX TTM operating income has changed by -$1.30 M (-32.73%)